Board/Management Information • Jan 5, 2026
Board/Management Information
Open in ViewerOpens in native device viewer

Lifecare ASA announces that the company's Chief Financial Officer (CFO), Renete Kaarvik, has accepted a new position outside Lifecare. She will remain in her role during a transition period, including throughout the ongoing rights issue, to ensure continuity in the company's financial processes. Kaarvik will subsequently step down as CFO.
The new position does not give rise to any conflicts of interest. Arrangements are being made to ensure continuity of the CFO function.
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.
For further information, please contact:
Joacim Holter, CEO, [email protected], +47 40 05 90 40
Renete Kaarvik, CFO, [email protected], +47 94 83 82 42
This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR Article 17. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-05 22:38 CET.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.